Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

Background Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. Meth...

Full description

Bibliographic Details
Main Authors: Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig H., Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew L.
Other Authors: Whitaker College of Health Sciences and Technology
Format: Article
Language:en_US
Published: Public Library of Science 2011
Online Access:http://hdl.handle.net/1721.1/66570

Similar Items

Similar Items